Obesity, diabetes and glycaemic control are inter-linked. Weight gain is associated with worsening diabetic control and can be exacerbated by therapies aimed at controlling hyperglycaemia. Auditing our practice in a district general hospital, we have examined our diabetic population with regards to age and weight, HbA1C and body mass index (BMI), and for weight gain following conversion to insulin.
Manson JE, Willett WC, Stampfer MJ et al. Body weight and mortality among women. N Engl J Med1995;333:677-85.
6.
Chinn S., Rona R.Prevalence and trends in overweight and obesity in three cross sectional studies in British children, 1974-94. BMJ2001;322: 24-6.
7.
Campbell K., Waters E., O'Meara S. et al. Interventions for preventing obesity in children (Cochrane Review). Issue 1. The Cochrane Library, Oxford: Update Software, 2003.
8.
Pinkney J.Implications of obesity for diabetes and coronary heart disease in clinical practice. Br J Diabetes Vasc Dis2001;1:103-06.
9.
Tattersall R.Diseases the doctor (or auto analyser) says you have got. Clin Med JRCPL2001;1:230-3.
10.
Andel M., Tattersall R.Authoritarianism in Diabetology. Diabet Med1989;6:471.
11.
Leslie P., Jung RT, Isles TE et al. Effect of optimal glycaemic control with continuous subcutaneous insulin infusion on energy expenditure in type 1 diabetes mellitus. BMJ1986;293:1121-6.
12.
Genuth S.Insulin use in NIDDM. Diabetes Care1990;13:1240-64.
13.
Gardner SG, Dunuchie S., Levy JCAudit of initiation of insulin treatment in type 2 diabetes. Diabet Med2002;19:187.
14.
Moleele GT, Marshall J., Mansell P.At what level do patients with type 2 diabetes benefit from insulin?Diabet Med2002;19:188.
15.
Cavan DA, Perrott T., Kerr D.Towards the paperless diabetes centre. Diabet Med2001;18:101.
16.
Campbell L. , Rossner S.Management of obesity in patients with type 2 diabetes. Diabet Med2001;18:345-54.
17.
Pugh JA, Wagner ML, Sawyer J. et al. Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A meta-analysis. Diabetes Care1992 ;15:953-9.
18.
Sane T., Helve E., Yki-jarvinen H. et al. One-year response to evening insulin therapy in non-insulin-dependent diabetes. J Intern Med1992;231:253-60.
19.
Flanagan DE, Holt H., Thomas P. et al. The clinical reality of switching to insulin in type 2 diabetes . Unpublished data.
20.
Diabetes Prevention ProgramResearch Group.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin . N Engl J Med2002;346:393-403.
21.
Toumilehto J., Lindstrom J., Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med2001;344:1343-50.
